Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Simon Senanu: Key Laboratory Markers of Hemolytic Anemia
Simon Senanu
Mar 28, 2026, 18:52

Simon Senanu: Key Laboratory Markers of Hemolytic Anemia

Simon Senanu, Medical Laboratory Scientist at Perkins Medical Centre, shared a post on LinkedIn:

“Hemolytic Anemia – Key Laboratory Markers

Hemolytic anemia is not just about low hemoglobin – it’s about increased red cell destruction.

And in the lab, the evidence is often unmistakable.

What Is Hemolytic Anemia?

Hemolytic anemia occurs when:

  • Red blood cell destruction exceeds bone marrow production

It can be broadly classified as:

  • Intravascular hemolysis – destruction within the circulation
  • Extravascular hemolysis – destruction by macrophages in the spleen and liver
  • The distinction is critical, as it directly influences both laboratory findings and clinical presentation.

Core Laboratory Markers

The diagnosis relies on a combination of findings:

  • Elevated Lactate Dehydrogenase (LDH) – Reflects cellular breakdown; often markedly increased in intravascular hemolysis
  • Increased Unconjugated Bilirubin – Result of heme catabolism; may lead to clinical jaundice
  • Reduced Haptoglobin – Binds free hemoglobin; levels drop as it is consumed – Often undetectable in intravascular hemolysis
  • Reticulocytosis -Indicates marrow compensation, Reticulocyte count may rise within 3 – 5 days of hemolysis

A high reticulocyte count with anemia strongly suggests a hemolytic process.

Peripheral Blood Smear Findings

The blood film is indispensable in narrowing the cause:

  • Schistocytes – Microangiopathic hemolytic anemia (e.g., TTP, DIC)
  • Spherocytes – Autoimmune hemolytic anemia or hereditary spherocytosis
  • Bite cells / Heinz body remnants – Oxidative damage (e.g., G6PD deficiency)
  • Polychromasia – Reflects increased circulating reticulocytes

In many cases, the smear provides the first clue to etiology before confirmatory testing.

Intravascular vs Extravascular Clues

  • Intravascular hemolysis
  • Hemoglobinemia
  • Hemoglobinuria
  • Markedly low haptoglobin

Extravascular hemolysis

  • Splenomegaly
  • Spherocytes on smear
  • Mildly reduced haptoglobin
  • These patterns help localize where destruction is occurring.

Additional Diagnostic Tests

To further define etiology:

  • Direct Antiglobulin Test (DAT / Coombs test) – Autoimmune hemolysis
  • G6PD assay – Enzyme deficiency (note: may be falsely normal during acute episodes)
  • Hemoglobin electrophoresis – Hemoglobinopathies
  • Osmotic fragility test – Hereditary spherocytosis

Laboratory Pitfalls

  • Recent transfusion may mask hemolysis markers
  • Liver disease can alter bilirubin interpretation
  • Inflammation may falsely elevate haptoglobin

Always interpret results in clinical context.

Clinical Significance

Early recognition of hemolysis is critical for:

  • Diagnosing autoimmune hemolytic anemia
  • Detecting transfusion reactions
  • Identifying inherited RBC disorders

Laboratory Takeaway

Hemolytic anemia is a pattern-based diagnosis.

No single test is sufficient – interpretation requires integrating:

  • Biochemistry plus Hematology plus Morphology

Which marker do you find most reliable in early hemolysis – LDH, haptoglobin, or the peripheral smear?”

Simon Senanu

Stay updated with Hemostasis Today.

haptoglobin Health Hematology Hemolytic anemia Hemostasis Hemostasis News Hemostasis Today Lactate Dehydrogenase LDH Medicine Peripheral Smear Simon Senanu
NewsFeed